Levitate Bio’s CEO Sam DeLuca, left, and Karen Khar, executive vice president of sales and business development. (LinkedIn Photos) Seattle startup Cyrus Biotechnology is spinning out a business that ...
The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...
Digitized R&D workflows help cell therapy developers reduce manual data handling and accelerate biologics development.
Science and technology have been a cornerstone of the U.S. defense enterprise for more than a century. The Defense Science Board (DSB) was created in the mid-1950s to leverage science and technology ...
Initiative creates new resource to support and accelerate early-stage therapeutics companies Parexel forms inaugural partnership with Durham-based Cape Fear BioCapital to connect incubator to a ...
Hong Kong, SAR--(Newsfile Corp. - June 24, 2024) - Hong Kong Science Park Corporation (HKSTP) congratulates BioMap, a Park company, on its strategic partnership with the Hong Kong Investment ...
Out of five critical tech sectors, "China has the most immediate opportunity to overtake the United States in biotechnology," the Harvard Belfer Center said in a new report. Just as China is ...
LILLE, France & PARIS--(BUSINESS WIRE)--4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that ...
Congress established the National Security Commission on Emerging Biotechnology (NSCEB) in the Fiscal Year 2022 National Defense Authorization Act “to examine and make recommendations with respect to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results